Anja Waldmann

577 total citations
6 papers, 468 citations indexed

About

Anja Waldmann is a scholar working on Oncology, Immunology and Otorhinolaryngology. According to data from OpenAlex, Anja Waldmann has authored 6 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Immunology and 1 paper in Otorhinolaryngology. Recurrent topics in Anja Waldmann's work include CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (5 papers) and T-cell and B-cell Immunology (2 papers). Anja Waldmann is often cited by papers focused on CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (5 papers) and T-cell and B-cell Immunology (2 papers). Anja Waldmann collaborates with scholars based in Germany and United States. Anja Waldmann's co-authors include Winfried S. Wels, Pranav Oberoi, Congcong Zhang, Sarah Oelsner, Torsten Tonn, Evelyn Ullrich, Jasmin Röder, Judith Bergs, Boris Brill and Peter Bader and has published in prestigious journals such as International Journal of Cancer, Frontiers in Immunology and Molecular Therapy.

In The Last Decade

Anja Waldmann

6 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anja Waldmann Germany 5 381 369 75 51 41 6 468
Nawid Albinger Germany 6 212 0.6× 279 0.8× 107 1.4× 57 1.1× 49 1.2× 9 349
Lois Hageman Netherlands 10 289 0.8× 315 0.9× 69 0.9× 49 1.0× 29 0.7× 14 419
Kevin M. Friedman United States 8 283 0.7× 405 1.1× 193 2.6× 55 1.1× 67 1.6× 15 530
Liora M. Schultz United States 10 202 0.5× 347 0.9× 132 1.8× 77 1.5× 50 1.2× 41 455
Antonio Valeri Spain 12 303 0.8× 294 0.8× 124 1.7× 60 1.2× 96 2.3× 23 462
Daijing Yuan China 7 149 0.4× 314 0.9× 114 1.5× 39 0.8× 36 0.9× 10 402
Susanne Wilde Germany 13 430 1.1× 345 0.9× 142 1.9× 100 2.0× 28 0.7× 20 542
Silke Landmeier Germany 11 351 0.9× 399 1.1× 83 1.1× 105 2.1× 32 0.8× 12 545
Maja Todorovic Italy 8 313 0.8× 307 0.8× 66 0.9× 42 0.8× 30 0.7× 11 401
Alexander Biederstädt Germany 5 402 1.1× 375 1.0× 155 2.1× 45 0.9× 49 1.2× 9 604

Countries citing papers authored by Anja Waldmann

Since Specialization
Citations

This map shows the geographic impact of Anja Waldmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Waldmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Waldmann more than expected).

Fields of papers citing papers by Anja Waldmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anja Waldmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Waldmann. The network helps show where Anja Waldmann may publish in the future.

Co-authorship network of co-authors of Anja Waldmann

This figure shows the co-authorship network connecting the top 25 collaborators of Anja Waldmann. A scholar is included among the top collaborators of Anja Waldmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja Waldmann. Anja Waldmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Röder, Jasmin, Tijna Alekseeva, Congcong Zhang, et al.. (2025). ErbB2/HER2-targeted CAR-NK cells eliminate breast cancer cells in an organoid model that recapitulates tumor progression. Molecular Therapy. 33(8). 3559–3575. 2 indexed citations
2.
Zhang, Congcong, Jasmin Röder, Anne Scherer, et al.. (2021). Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity. Journal for ImmunoTherapy of Cancer. 9(10). e002980–e002980. 48 indexed citations
3.
Oelsner, Sarah, Anja Waldmann, Jasmin Röder, et al.. (2019). Genetically engineered CAR NK cells display selective cytotoxicity against FLT3‐positive B‐ALL and inhibit in vivo leukemia growth. International Journal of Cancer. 145(7). 1935–1945. 71 indexed citations
4.
Wagner, Juliane, Anja Waldmann, Judith Bergs, et al.. (2017). A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma. Frontiers in Immunology. 8. 676–676. 82 indexed citations
5.
Zhang, Congcong, Pranav Oberoi, Sarah Oelsner, et al.. (2017). Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity. Frontiers in Immunology. 8. 533–533. 258 indexed citations
6.
Böscke, Robert, et al.. (2014). Immune Imbalance in Nasal Polyps of Caucasian Chronic Rhinosinusitis Patients Is Associated with a Downregulation of E-Selectin. Journal of Immunology Research. 2014. 1–8. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026